InvestorsHub Logo
Followers 8
Posts 481
Boards Moderated 0
Alias Born 02/03/2021

Re: None

Sunday, 06/27/2021 12:10:13 AM

Sunday, June 27, 2021 12:10:13 AM

Post# of 232969
One of the drugs used in the CD12 SOC was Tocilizumab. Given that it has now been given EUA for also critical ECMO, it would be of interest to know how we fared against it in cd12 especially among critical patients.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News